FDA approves Eagle Pharmaceuticals’ Ryanodex® for the treatment - TopicsExpress



          

FDA approves Eagle Pharmaceuticals’ Ryanodex® for the treatment of malignant hyperthermia. Ryanodex is available in single-use vials containing 250mg of dantrolene sodium in lyophilized powder form. It is formulated for rapid reconstitution and administration in less than one minute to patients in malignant hyperthermia crisis. Read more at aana/resources2/professionalpractice/Documents/Eagle-Ryanodex-Release-Final.pdf
Posted on: Wed, 23 Jul 2014 14:30:43 +0000

Trending Topics



Recently Viewed Topics




© 2015